Debiopharm is an independent biopharmaceutical company based in Switzerland, focused on developing prescription drugs targeting unmet medical needs in oncology and bacterial infections. They also have a strategic corporate fund, Debiopharm Innovation Fund, which invests in startups transforming Pharma R&D and cancer care.
Focus Areas
Notable Investments
